Central and Peripheral Molecular Targets for Antiobesity Pharmacotherapy

Regulatory challenges for new drugs to treat obesity and comorbid metabolic disorders

(2009) David J. Heal et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

New central targets for the treatment of obesity

(2009) Bruce J. Sargent et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Endoplasmic Reticulum Stress Plays a Central Role in Development of Leptin Resistance

(2009) Lale Ozcan et al.   Cell Metabolism

The histamine H3 receptor as a therapeutic drug target for CNS disorders

(2009) Mark J. Gemkow et al.   DRUG DISCOVERY TODAY

Gut Peptides: Targets for Antiobesity Drug Development?

(2009) Timothy H. Moran et al.   ENDOCRINOLOGY

Rational Design of a Combination Medication for the Treatment of Obesity

(2008) Frank L. Greenway et al.   Obesity

Inhibition of ghrelin O-acyltransferase (GOAT) by octanoylated pentapeptides

(2008) J. Yang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Leptin responsiveness restored by amylin agonism in diet-induced obesity: Evidence from nonclinical and clinical studies

(2008) J. D. Roth et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA